best glp-1 drug for weight loss Options Atrafen GLP Ultra GLP-1 Appetite

Wong HJ, Sim B, Teo YH, et al

Given the divergent outcomes of these studies, the efficacies of GLP-1R agonists for opioid-related responses need to be investigated in greater detail

Compounded GLP-1 medications require evaluation by a licensed clinician

77 A meta-analysis of 76 RCTs, involving over 100,000 adults with overweight, obesity, or type 2 diabetes found that GLP-1 RA treatment, compared to placebo or other active comparators, was associated with a modestly elevated risk of cholelithiasis (RR: 1.27, 95% CI 1.10, 1.47), cholecystitis (RR: 1.36, 95% CI 1.14, 1.62), and overall biliary disease (RR: 1.55, 95% CI 1.08, 2.22), corresponding to an absolute increase of approximately 27 events per 10,000 patients per year

doi: 10.1210/en.2010-0289 [DOI] [PMC free article] [PubMed] [Google Scholar] 43.Knauf C, Cani PD, Ait-Belgnaoui A, et al

For the most up-to-date information, visit the Novo Nordisk PAP website or contact their support